Industry Research Reports
Home > Reports > Pharma & Healthcare > NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
NAD+ Intravenous Therapy Market Size(US$)
CAGR 2025-2031
7.5%
Market Size,2031
USD 479
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 311 million
Market Forecast in 2031(Value)
US$ 479 million
CAGR
7.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
NAD+ IV Therapy is a wellness therapy that involves the intravenous administration of nicotinamide adenine dinucleotide (NAD+), a coenzyme crucial for cellular energy production and metabolic processes. This therapy is believed to boost energy levels, enhance cognitive function, and promote overall cellular repair by increasing NAD+ levels, which naturally decline with age.
North American market for NAD+ Intravenous Therapy was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for NAD+ Intravenous Therapy was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for NAD+ Intravenous Therapy was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of NAD+ Intravenous Therapy include The Wellness Lab, Conciergemdla, Azivmedics, Reset IV, Thedripclub, Toronto Functional Medicine Centre, Mobileivmedics, Rocky Mountain Ivmedics, Seaside Skin Care, Premiumhealth, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for NAD+ Intravenous Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of NAD+ Intravenous Therapy by region & country, by Type, and by Application.
The NAD+ Intravenous Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding NAD+ Intravenous Therapy.
Market Segmentation
By Company
- The Wellness Lab
- Conciergemdla
- Azivmedics
- Reset IV
- Thedripclub
- Toronto Functional Medicine Centre
- Mobileivmedics
- Rocky Mountain Ivmedics
- Seaside Skin Care
- Premiumhealth
- Effect Doctors
- Nadclinic
- Hydrate IV Bar
- LIVV Natural
- BioReset Medical
- IV Boost UK
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- NAD+ Mixed Vitamin Injections
- Pure NAD+ Injection
Segment by Application
- Clinic
- Hospital
- Residential
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of NAD+ Intravenous Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of NAD+ Intravenous Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of NAD+ Intravenous Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Market Overview
1.1 NAD+ Intravenous Therapy Product Introduction
1.2 Global NAD+ Intravenous Therapy Market Size Forecast (2020-2031)
1.3 NAD+ Intravenous Therapy Market Trends & Drivers
1.3.1 NAD+ Intravenous Therapy Industry Trends
1.3.2 NAD+ Intravenous Therapy Market Drivers & Opportunity
1.3.3 NAD+ Intravenous Therapy Market Challenges
1.3.4 NAD+ Intravenous Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global NAD+ Intravenous Therapy Players Revenue Ranking (2024)
2.2 Global NAD+ Intravenous Therapy Revenue by Company (2020-2025)
2.3 Key Companies NAD+ Intravenous Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies NAD+ Intravenous Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of NAD+ Intravenous Therapy
2.6 NAD+ Intravenous Therapy Market Competitive Analysis
2.6.1 NAD+ Intravenous Therapy Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by NAD+ Intravenous Therapy Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Intravenous Therapy as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 NAD+ Mixed Vitamin Injections
3.1.2 Pure NAD+ Injection
3.2 Global NAD+ Intravenous Therapy Sales Value by Type
3.2.1 Global NAD+ Intravenous Therapy Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global NAD+ Intravenous Therapy Sales Value, by Type (2020-2031)
3.2.3 Global NAD+ Intravenous Therapy Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinic
4.1.2 Hospital
4.1.3 Residential
4.2 Global NAD+ Intravenous Therapy Sales Value by Application
4.2.1 Global NAD+ Intravenous Therapy Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global NAD+ Intravenous Therapy Sales Value, by Application (2020-2031)
4.2.3 Global NAD+ Intravenous Therapy Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global NAD+ Intravenous Therapy Sales Value by Region
5.1.1 Global NAD+ Intravenous Therapy Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global NAD+ Intravenous Therapy Sales Value by Region (2020-2025)
5.1.3 Global NAD+ Intravenous Therapy Sales Value by Region (2026-2031)
5.1.4 Global NAD+ Intravenous Therapy Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America NAD+ Intravenous Therapy Sales Value, 2020-2031
5.2.2 North America NAD+ Intravenous Therapy Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe NAD+ Intravenous Therapy Sales Value, 2020-2031
5.3.2 Europe NAD+ Intravenous Therapy Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific NAD+ Intravenous Therapy Sales Value, 2020-2031
5.4.2 Asia Pacific NAD+ Intravenous Therapy Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America NAD+ Intravenous Therapy Sales Value, 2020-2031
5.5.2 South America NAD+ Intravenous Therapy Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa NAD+ Intravenous Therapy Sales Value, 2020-2031
5.6.2 Middle East & Africa NAD+ Intravenous Therapy Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions NAD+ Intravenous Therapy Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions NAD+ Intravenous Therapy Sales Value, 2020-2031
6.3 United States
6.3.1 United States NAD+ Intravenous Therapy Sales Value, 2020-2031
6.3.2 United States NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
6.3.3 United States NAD+ Intravenous Therapy Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe NAD+ Intravenous Therapy Sales Value, 2020-2031
6.4.2 Europe NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe NAD+ Intravenous Therapy Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China NAD+ Intravenous Therapy Sales Value, 2020-2031
6.5.2 China NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
6.5.3 China NAD+ Intravenous Therapy Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan NAD+ Intravenous Therapy Sales Value, 2020-2031
6.6.2 Japan NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan NAD+ Intravenous Therapy Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea NAD+ Intravenous Therapy Sales Value, 2020-2031
6.7.2 South Korea NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea NAD+ Intravenous Therapy Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia NAD+ Intravenous Therapy Sales Value, 2020-2031
6.8.2 Southeast Asia NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia NAD+ Intravenous Therapy Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India NAD+ Intravenous Therapy Sales Value, 2020-2031
6.9.2 India NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
6.9.3 India NAD+ Intravenous Therapy Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 The Wellness Lab
7.1.1 The Wellness Lab Profile
7.1.2 The Wellness Lab Main Business
7.1.3 The Wellness Lab NAD+ Intravenous Therapy Products, Services and Solutions
7.1.4 The Wellness Lab NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.1.5 The Wellness Lab Recent Developments
7.2 Conciergemdla
7.2.1 Conciergemdla Profile
7.2.2 Conciergemdla Main Business
7.2.3 Conciergemdla NAD+ Intravenous Therapy Products, Services and Solutions
7.2.4 Conciergemdla NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.2.5 Conciergemdla Recent Developments
7.3 Azivmedics
7.3.1 Azivmedics Profile
7.3.2 Azivmedics Main Business
7.3.3 Azivmedics NAD+ Intravenous Therapy Products, Services and Solutions
7.3.4 Azivmedics NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.3.5 Azivmedics Recent Developments
7.4 Reset IV
7.4.1 Reset IV Profile
7.4.2 Reset IV Main Business
7.4.3 Reset IV NAD+ Intravenous Therapy Products, Services and Solutions
7.4.4 Reset IV NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.4.5 Reset IV Recent Developments
7.5 Thedripclub
7.5.1 Thedripclub Profile
7.5.2 Thedripclub Main Business
7.5.3 Thedripclub NAD+ Intravenous Therapy Products, Services and Solutions
7.5.4 Thedripclub NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.5.5 Thedripclub Recent Developments
7.6 Toronto Functional Medicine Centre
7.6.1 Toronto Functional Medicine Centre Profile
7.6.2 Toronto Functional Medicine Centre Main Business
7.6.3 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Products, Services and Solutions
7.6.4 Toronto Functional Medicine Centre NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.6.5 Toronto Functional Medicine Centre Recent Developments
7.7 Mobileivmedics
7.7.1 Mobileivmedics Profile
7.7.2 Mobileivmedics Main Business
7.7.3 Mobileivmedics NAD+ Intravenous Therapy Products, Services and Solutions
7.7.4 Mobileivmedics NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.7.5 Mobileivmedics Recent Developments
7.8 Rocky Mountain Ivmedics
7.8.1 Rocky Mountain Ivmedics Profile
7.8.2 Rocky Mountain Ivmedics Main Business
7.8.3 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Products, Services and Solutions
7.8.4 Rocky Mountain Ivmedics NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.8.5 Rocky Mountain Ivmedics Recent Developments
7.9 Seaside Skin Care
7.9.1 Seaside Skin Care Profile
7.9.2 Seaside Skin Care Main Business
7.9.3 Seaside Skin Care NAD+ Intravenous Therapy Products, Services and Solutions
7.9.4 Seaside Skin Care NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.9.5 Seaside Skin Care Recent Developments
7.10 Premiumhealth
7.10.1 Premiumhealth Profile
7.10.2 Premiumhealth Main Business
7.10.3 Premiumhealth NAD+ Intravenous Therapy Products, Services and Solutions
7.10.4 Premiumhealth NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.10.5 Premiumhealth Recent Developments
7.11 Effect Doctors
7.11.1 Effect Doctors Profile
7.11.2 Effect Doctors Main Business
7.11.3 Effect Doctors NAD+ Intravenous Therapy Products, Services and Solutions
7.11.4 Effect Doctors NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.11.5 Effect Doctors Recent Developments
7.12 Nadclinic
7.12.1 Nadclinic Profile
7.12.2 Nadclinic Main Business
7.12.3 Nadclinic NAD+ Intravenous Therapy Products, Services and Solutions
7.12.4 Nadclinic NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.12.5 Nadclinic Recent Developments
7.13 Hydrate IV Bar
7.13.1 Hydrate IV Bar Profile
7.13.2 Hydrate IV Bar Main Business
7.13.3 Hydrate IV Bar NAD+ Intravenous Therapy Products, Services and Solutions
7.13.4 Hydrate IV Bar NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.13.5 Hydrate IV Bar Recent Developments
7.14 LIVV Natural
7.14.1 LIVV Natural Profile
7.14.2 LIVV Natural Main Business
7.14.3 LIVV Natural NAD+ Intravenous Therapy Products, Services and Solutions
7.14.4 LIVV Natural NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.14.5 LIVV Natural Recent Developments
7.15 BioReset Medical
7.15.1 BioReset Medical Profile
7.15.2 BioReset Medical Main Business
7.15.3 BioReset Medical NAD+ Intravenous Therapy Products, Services and Solutions
7.15.4 BioReset Medical NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.15.5 BioReset Medical Recent Developments
7.16 IV Boost UK
7.16.1 IV Boost UK Profile
7.16.2 IV Boost UK Main Business
7.16.3 IV Boost UK NAD+ Intravenous Therapy Products, Services and Solutions
7.16.4 IV Boost UK NAD+ Intravenous Therapy Revenue (US$ Million) & (2020-2025)
7.16.5 IV Boost UK Recent Developments
8 Industry Chain Analysis
8.1 NAD+ Intravenous Therapy Industrial Chain
8.2 NAD+ Intravenous Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 NAD+ Intravenous Therapy Sales Model
8.5.2 Sales Channel
8.5.3 NAD+ Intravenous Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. NAD+ Intravenous Therapy Market Trends
Table 2. NAD+ Intravenous Therapy Market Drivers & Opportunity
Table 3. NAD+ Intravenous Therapy Market Challenges
Table 4. NAD+ Intravenous Therapy Market Restraints
Table 5. Global NAD+ Intravenous Therapy Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global NAD+ Intravenous Therapy Revenue Market Share by Company (2020-2025)
Table 7. Key Companies NAD+ Intravenous Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies NAD+ Intravenous Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of NAD+ Intravenous Therapy
Table 10. Global NAD+ Intravenous Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Intravenous Therapy as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global NAD+ Intravenous Therapy Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global NAD+ Intravenous Therapy Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global NAD+ Intravenous Therapy Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global NAD+ Intravenous Therapy Sales Market Share in Value by Type (2020-2025)
Table 17. Global NAD+ Intravenous Therapy Sales Market Share in Value by Type (2026-2031)
Table 18. Global NAD+ Intravenous Therapy Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global NAD+ Intravenous Therapy Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global NAD+ Intravenous Therapy Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global NAD+ Intravenous Therapy Sales Market Share in Value by Application (2020-2025)
Table 22. Global NAD+ Intravenous Therapy Sales Market Share in Value by Application (2026-2031)
Table 23. Global NAD+ Intravenous Therapy Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global NAD+ Intravenous Therapy Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global NAD+ Intravenous Therapy Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global NAD+ Intravenous Therapy Sales Value by Region (2020-2025) & (%)
Table 27. Global NAD+ Intravenous Therapy Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions NAD+ Intravenous Therapy Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions NAD+ Intravenous Therapy Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions NAD+ Intravenous Therapy Sales Value, (2026-2031) & (US$ Million)
Table 31. The Wellness Lab Basic Information List
Table 32. The Wellness Lab Description and Business Overview
Table 33. The Wellness Lab NAD+ Intravenous Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of The Wellness Lab (2020-2025)
Table 35. The Wellness Lab Recent Developments
Table 36. Conciergemdla Basic Information List
Table 37. Conciergemdla Description and Business Overview
Table 38. Conciergemdla NAD+ Intravenous Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Conciergemdla (2020-2025)
Table 40. Conciergemdla Recent Developments
Table 41. Azivmedics Basic Information List
Table 42. Azivmedics Description and Business Overview
Table 43. Azivmedics NAD+ Intravenous Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Azivmedics (2020-2025)
Table 45. Azivmedics Recent Developments
Table 46. Reset IV Basic Information List
Table 47. Reset IV Description and Business Overview
Table 48. Reset IV NAD+ Intravenous Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Reset IV (2020-2025)
Table 50. Reset IV Recent Developments
Table 51. Thedripclub Basic Information List
Table 52. Thedripclub Description and Business Overview
Table 53. Thedripclub NAD+ Intravenous Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Thedripclub (2020-2025)
Table 55. Thedripclub Recent Developments
Table 56. Toronto Functional Medicine Centre Basic Information List
Table 57. Toronto Functional Medicine Centre Description and Business Overview
Table 58. Toronto Functional Medicine Centre NAD+ Intravenous Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Toronto Functional Medicine Centre (2020-2025)
Table 60. Toronto Functional Medicine Centre Recent Developments
Table 61. Mobileivmedics Basic Information List
Table 62. Mobileivmedics Description and Business Overview
Table 63. Mobileivmedics NAD+ Intravenous Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Mobileivmedics (2020-2025)
Table 65. Mobileivmedics Recent Developments
Table 66. Rocky Mountain Ivmedics Basic Information List
Table 67. Rocky Mountain Ivmedics Description and Business Overview
Table 68. Rocky Mountain Ivmedics NAD+ Intravenous Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Rocky Mountain Ivmedics (2020-2025)
Table 70. Rocky Mountain Ivmedics Recent Developments
Table 71. Seaside Skin Care Basic Information List
Table 72. Seaside Skin Care Description and Business Overview
Table 73. Seaside Skin Care NAD+ Intravenous Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Seaside Skin Care (2020-2025)
Table 75. Seaside Skin Care Recent Developments
Table 76. Premiumhealth Basic Information List
Table 77. Premiumhealth Description and Business Overview
Table 78. Premiumhealth NAD+ Intravenous Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Premiumhealth (2020-2025)
Table 80. Premiumhealth Recent Developments
Table 81. Effect Doctors Basic Information List
Table 82. Effect Doctors Description and Business Overview
Table 83. Effect Doctors NAD+ Intravenous Therapy Products, Services and Solutions
Table 84. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Effect Doctors (2020-2025)
Table 85. Effect Doctors Recent Developments
Table 86. Nadclinic Basic Information List
Table 87. Nadclinic Description and Business Overview
Table 88. Nadclinic NAD+ Intravenous Therapy Products, Services and Solutions
Table 89. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Nadclinic (2020-2025)
Table 90. Nadclinic Recent Developments
Table 91. Hydrate IV Bar Basic Information List
Table 92. Hydrate IV Bar Description and Business Overview
Table 93. Hydrate IV Bar NAD+ Intravenous Therapy Products, Services and Solutions
Table 94. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of Hydrate IV Bar (2020-2025)
Table 95. Hydrate IV Bar Recent Developments
Table 96. LIVV Natural Basic Information List
Table 97. LIVV Natural Description and Business Overview
Table 98. LIVV Natural NAD+ Intravenous Therapy Products, Services and Solutions
Table 99. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of LIVV Natural (2020-2025)
Table 100. LIVV Natural Recent Developments
Table 101. BioReset Medical Basic Information List
Table 102. BioReset Medical Description and Business Overview
Table 103. BioReset Medical NAD+ Intravenous Therapy Products, Services and Solutions
Table 104. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of BioReset Medical (2020-2025)
Table 105. BioReset Medical Recent Developments
Table 106. IV Boost UK Basic Information List
Table 107. IV Boost UK Description and Business Overview
Table 108. IV Boost UK NAD+ Intravenous Therapy Products, Services and Solutions
Table 109. Revenue (US$ Million) in NAD+ Intravenous Therapy Business of IV Boost UK (2020-2025)
Table 110. IV Boost UK Recent Developments
Table 111. Key Raw Materials Lists
Table 112. Raw Materials Key Suppliers Lists
Table 113. NAD+ Intravenous Therapy Downstream Customers
Table 114. NAD+ Intravenous Therapy Distributors List
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. NAD+ Intravenous Therapy Product Picture
Figure 2. Global NAD+ Intravenous Therapy Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global NAD+ Intravenous Therapy Sales Value (2020-2031) & (US$ Million)
Figure 4. NAD+ Intravenous Therapy Report Years Considered
Figure 5. Global NAD+ Intravenous Therapy Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by NAD+ Intravenous Therapy Revenue in 2024
Figure 7. NAD+ Intravenous Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. NAD+ Mixed Vitamin Injections Picture
Figure 9. Pure NAD+ Injection Picture
Figure 10. Global NAD+ Intravenous Therapy Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global NAD+ Intravenous Therapy Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Clinic
Figure 13. Product Picture of Hospital
Figure 14. Product Picture of Residential
Figure 15. Global NAD+ Intravenous Therapy Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global NAD+ Intravenous Therapy Sales Value Market Share by Application, 2024 & 2031
Figure 17. North America NAD+ Intravenous Therapy Sales Value (2020-2031) & (US$ Million)
Figure 18. North America NAD+ Intravenous Therapy Sales Value by Country (%), 2024 VS 2031
Figure 19. Europe NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 20. Europe NAD+ Intravenous Therapy Sales Value by Country (%), 2024 VS 2031
Figure 21. Asia Pacific NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 22. Asia Pacific NAD+ Intravenous Therapy Sales Value by Region (%), 2024 VS 2031
Figure 23. South America NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 24. South America NAD+ Intravenous Therapy Sales Value by Country (%), 2024 VS 2031
Figure 25. Middle East & Africa NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 26. Middle East & Africa NAD+ Intravenous Therapy Sales Value by Country (%), 2024 VS 2031
Figure 27. Key Countries/Regions NAD+ Intravenous Therapy Sales Value (%), (2020-2031)
Figure 28. United States NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 29. United States NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
Figure 30. United States NAD+ Intravenous Therapy Sales Value by Application (%), 2024 VS 2031
Figure 31. Europe NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
Figure 33. Europe NAD+ Intravenous Therapy Sales Value by Application (%), 2024 VS 2031
Figure 34. China NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 35. China NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
Figure 36. China NAD+ Intravenous Therapy Sales Value by Application (%), 2024 VS 2031
Figure 37. Japan NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 38. Japan NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
Figure 39. Japan NAD+ Intravenous Therapy Sales Value by Application (%), 2024 VS 2031
Figure 40. South Korea NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 41. South Korea NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
Figure 42. South Korea NAD+ Intravenous Therapy Sales Value by Application (%), 2024 VS 2031
Figure 43. Southeast Asia NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 44. Southeast Asia NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
Figure 45. Southeast Asia NAD+ Intravenous Therapy Sales Value by Application (%), 2024 VS 2031
Figure 46. India NAD+ Intravenous Therapy Sales Value, (2020-2031) & (US$ Million)
Figure 47. India NAD+ Intravenous Therapy Sales Value by Type (%), 2024 VS 2031
Figure 48. India NAD+ Intravenous Therapy Sales Value by Application (%), 2024 VS 2031
Figure 49. NAD+ Intravenous Therapy Industrial Chain
Figure 50. NAD+ Intravenous Therapy Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Related Reports
Global NAD+ Intravenous Therapy Market Insights, Forecast to 2030
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 449 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Published Date: 2024-11-11
Pages: 154
USD 4900.00
(Single User License)
Global and United States NAD+ Intravenous Therapy Market Report & Forecast 2024-2030
The global NAD+ Intravenous Therapy revenue was US$ 281 million in 2023 and is forecast to a readjusted size of US$ 449 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).
Published Date: 2024-11-11
Pages: 131
USD 4350.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2024
The global NAD+ Intravenous Therapy market was valued at US$ 281 million in 2023 and is anticipated to reach US$ 449 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Published Date: 2024-11-11
Pages: 100
USD 2900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2025
The global market for NAD+ Intravenous Therapy was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 479 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published Date: 2025-03-13
Pages: 97
USD 2900.00
(Single User License)
Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global NAD+ Intravenous Therapy market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 105
USD 4250.00
(Single User License)
Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 479 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 158
USD 4900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Research Report 2026
The global NAD+ Intravenous Therapy market was valued at US$ 99 million in 2025 and is anticipated to reach US$ 171 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-31
Pages: 117
USD 2900.00
(Single User License)
NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 99 million in 2025 and is projected to reach US$ 171 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published Date: 2026-01-31
Pages: 105
USD 3950.00
(Single User License)
Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global NAD+ Intravenous Therapy market size was US$ 99 million in 2025 and is forecast to reach a readjusted size of US$ 171 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 94
USD 4250.00
(Single User License)
Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global NAD+ Intravenous Therapy market is projected to grow from US$ 99 million in 2025 to US$ 171 million by 2032, at a CAGR of 8.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 133
USD 4900.00
(Single User License)
Global NAD+ Intravenous Therapy Market Insights, Forecast to 2030
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 449 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Published: 2024-11-11
Pages: 154
USD 4900.00 (Single User License)Global and United States NAD+ Intravenous Therapy Market Report & Forecast 2024-2030
The global NAD+ Intravenous Therapy revenue was US$ 281 million in 2023 and is forecast to a readjusted size of US$ 449 million by 2030 with a CAGR of 7.5% during the review period (2024-2030).
Published: 2024-11-11
Pages: 131
USD 4350.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2024
The global NAD+ Intravenous Therapy market was valued at US$ 281 million in 2023 and is anticipated to reach US$ 449 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Published: 2024-11-11
Pages: 100
USD 2900.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2025
The global market for NAD+ Intravenous Therapy was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 479 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Published: 2025-03-13
Pages: 97
USD 2900.00 (Single User License)Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global NAD+ Intravenous Therapy market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 479 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 105
USD 4250.00 (Single User License)Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2031
The global NAD+ Intravenous Therapy market is projected to grow from US$ 291 million in 2024 to US$ 479 million by 2031, at a CAGR of 7.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 158
USD 4900.00 (Single User License)Global NAD+ Intravenous Therapy Market Research Report 2026
The global NAD+ Intravenous Therapy market was valued at US$ 99 million in 2025 and is anticipated to reach US$ 171 million by 2032, at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-31
Pages: 117
USD 2900.00 (Single User License)NAD+ Intravenous Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for NAD+ Intravenous Therapy was estimated to be worth US$ 99 million in 2025 and is projected to reach US$ 171 million, growing at a CAGR of 8.3% from 2026 to 2032.
Published: 2026-01-31
Pages: 105
USD 3950.00 (Single User License)Global NAD+ Intravenous Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global NAD+ Intravenous Therapy market size was US$ 99 million in 2025 and is forecast to reach a readjusted size of US$ 171 million by 2032 with a CAGR of 8.3% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 94
USD 4250.00 (Single User License)Global NAD+ Intravenous Therapy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global NAD+ Intravenous Therapy market is projected to grow from US$ 99 million in 2025 to US$ 171 million by 2032, at a CAGR of 8.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 133
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research